Rituximab (intrathecal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rituximab (intrathecal), covering 2023-03-29 to 2023-03-29. Get the full timeline:
Most recent: Clinical Trial Update: Intrathecal Rituximab With Standard Intrathecal Prophylaxis to Prevent CNS Relapse for CD 20+ Non Hodgkin Lymphoma [Phase 2]